With a cutoff value for serum SCCA–IgM at >200 AU/mL, SCCA–IgM was significantly higher in SSc patients with ILD, which is a major determinant of the prognosis in SSc patients, than in those without ILD [45]. The gene discussed is CD40LG; the disease is systemic sclerosis.